Intraperitoneal Atomization of Levobupivacaine During Gynaecological Laparoscopic Procedures ; Impact on Pain, Opioid Use and Length of Recovery Room Stay (IPLA).

Trial Profile

Intraperitoneal Atomization of Levobupivacaine During Gynaecological Laparoscopic Procedures ; Impact on Pain, Opioid Use and Length of Recovery Room Stay (IPLA).

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Levobupivacaine (Primary) ; Levobupivacaine (Primary) ; Diclofenac; Opioid analgesics; Paracetamol
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms IPLA
  • Most Recent Events

    • 04 Dec 2014 Planned End Date changed from 1 Jul 2014 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
    • 04 Dec 2014 Planned primary completion date changed from 1 Jul 2014 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
    • 14 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top